Inhibikase Therapeutics, Inc. (IKT)

NASDAQ: IKT · IEX Real-Time Price · USD

1.730

-0.030 (-1.70%)

At close: May 17, 2024, 4:00 PM

1.900

+0.170 (9.83%)

After-hours: May 17, 2024, 5:30 PM EDT

Inhibikase Therapeutics Market Cap

Inhibikase Therapeutics has a market cap or net worth of $11.17 million as of May 17, 2024. Its market cap has decreased by -37.58% in one year.

Market Cap

11.17M

Enterprise Value

1.91M

1-Year Change

-37.58%

Ranking

#5207

Market Cap Chart

Since the IPO on December 23, 2020, Inhibikase Therapeutics's market cap has decreased from $100.46M to $11.17M, a decrease of -88.88%. That is a compound annual growth rate of -47.58%.

Market Cap History

Date	Market Cap	% Change
May 17, 2024	11.20M	-1.75%
May 16, 2024	11.40M	-11.63%
May 15, 2024	12.90M	29.00%
May 14, 2024	10.00M	13.64%
May 13, 2024	8.80M	3.53%
May 10, 2024	8.50M	-3.41%
May 9, 2024	8.80M	-3.30%
May 8, 2024	9.10M	10.98%
May 7, 2024	8.20M	-2.38%
May 6, 2024	8.40M	-6.67%
May 3, 2024	9.00M	3.45%
May 2, 2024	8.70M	-
May 1, 2024	8.70M	-8.42%
Apr 30, 2024	9.50M	-7.77%
Apr 29, 2024	10.30M	-7.21%
Apr 26, 2024	11.10M	-9.76%
Apr 25, 2024	12.30M	1.65%
Apr 24, 2024	12.10M	18.63%
Apr 23, 2024	10.20M	14.61%
Apr 22, 2024	8.90M	-32.58%
Apr 19, 2024	13.20M	-2.94%
Apr 18, 2024	13.60M	-1.45%
Apr 17, 2024	13.80M	-
Apr 16, 2024	13.80M	-2.82%
Apr 15, 2024	14.20M	-

View and export this data all the way back to 2020. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Centogene	11.70M
ABVC BioPharma	11.51M
iCoreConnect	11.47M
Moleculin Biotech	11.37M
BioCardia	11.02M
Elevai Labs	11.00M
CareMax	10.99M
Guardion Health Sciences	10.98M

Market Cap Rankings